Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tissue Engineering Grant Applications Sought By NIH; Organ Repair A Focus

This article was originally published in The Gray Sheet

Executive Summary

FDA will likely offer lab space and the assistance of agency researchers to support recipients of tissue engineering grant applications sought by the National Institute of Biomedical Imaging & Engineering

You may also be interested in...



NIBIB Scientific Program Reorganization Reflects Multidisciplinary Research

Training initiatives at the National Institute of Biomedical Imaging & Bioengineering will include a program for medical residents in radiology, NIBIB Senior Advisor for Special Projects Richard Swaja, PhD, told the institute's advisory council Jan. 16

NIBIB Scientific Program Reorganization Reflects Multidisciplinary Research

Training initiatives at the National Institute of Biomedical Imaging & Bioengineering will include a program for medical residents in radiology, NIBIB Senior Advisor for Special Projects Richard Swaja, PhD, told the institute's advisory council Jan. 16

Federal Tissue Engineering Research Role Discussed At FDA Science Forum

Federal funding for tissue engineering should be aimed at research to resolve scientific roadblocks in product development, according to TissueInformatics CEO Peter Johnson, MD

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017777

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel